These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 31378778)
1. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis. Hu J; Hu B; Gui YC; Tan ZB; Xu JW Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis. Yan S; Liu Z; Yu S; Bao Y Med Sci Monit; 2016 Sep; 22():3409-3418. PubMed ID: 27665580 [TBL] [Abstract][Full Text] [Related]
3. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study. Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic performances of methylated septin9 gene, CEA, CA19-9 and platelet-to-lymphocyte ratio in colorectal cancer. Sun Q; Long L BMC Cancer; 2024 Jul; 24(1):906. PubMed ID: 39068425 [TBL] [Abstract][Full Text] [Related]
5. Clinical value of preoperative methylated septin 9 in Chinese colorectal cancer patients. Yang X; Xu ZJ; Chen X; Zeng SS; Qian L; Wei J; Peng M; Wang X; Liu WL; Ma HY; Gong ZC; Yan YL World J Gastroenterol; 2019 May; 25(17):2099-2109. PubMed ID: 31114136 [TBL] [Abstract][Full Text] [Related]
6. Clinical diagnostic value of methylated SEPT9 combined with NLR, PLR and LMR in colorectal cancer. Huang M; Deng S; Li M; Yang Z; Guo J; Deng Y; Chen D; Yan B BMC Gastroenterol; 2024 Jul; 24(1):240. PubMed ID: 39075402 [TBL] [Abstract][Full Text] [Related]
7. The quantitative profiling of blood mSEPT9 determines the detection performance on colorectal tumors. Song L; Wang J; Wang H; Chen Y; Jia J; Guo S; Liu H; Peng X; Xiao W; Gong Y; Yang B; Lu Y; Li Y Epigenomics; 2018 Dec; 10(12):1569-1583. PubMed ID: 30426784 [TBL] [Abstract][Full Text] [Related]
8. The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location. Song L; Jia J; Yu H; Peng X; Xiao W; Gong Y; Zhou G; Han X; Li Y J Cancer Res Clin Oncol; 2017 Jun; 143(6):1093-1101. PubMed ID: 28224298 [TBL] [Abstract][Full Text] [Related]
9. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA. Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039 [TBL] [Abstract][Full Text] [Related]
10. Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer. Fu B; Yan P; Zhang S; Lu Y; Pan L; Tang W; Chen S; Chen S; Zhang A; Liu W Dis Markers; 2018; 2018():6437104. PubMed ID: 29849824 [TBL] [Abstract][Full Text] [Related]
11. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China. Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944 [TBL] [Abstract][Full Text] [Related]
12. Detection of Methylated SEPT9 in Korean Colorectal Cancer Patients: Comparison with Previous Studies. Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999 [TBL] [Abstract][Full Text] [Related]
13. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer. Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587 [TBL] [Abstract][Full Text] [Related]
14. The Clinical Significance of Septin 9 and Colon Cancer Specific Antigen-2 (CCSA-2) in Colorectal Cancer. Abd El Kader L; Soliman AH; Salem SE; Akel SY; Ibrahim NH Asian Pac J Cancer Prev; 2023 Mar; 24(3):1027-1036. PubMed ID: 36974558 [TBL] [Abstract][Full Text] [Related]
15. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm. Jin P; Kang Q; Wang X; Yang L; Yu Y; Li N; He YQ; Han X; Hang J; Zhang J; Song L; Han Y; Sheng JQ J Gastroenterol Hepatol; 2015 May; 30(5):830-3. PubMed ID: 25471329 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic Value of Methylated Xie L; Jiang X; Li Q; Sun Z; Quan W; Duan Y; Li D; Chen T Front Oncol; 2018; 8():247. PubMed ID: 30013949 [TBL] [Abstract][Full Text] [Related]
17. A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis. Song L; Yu H; Jia J; Li Y Cancer Biomark; 2017; 18(4):425-432. PubMed ID: 28128742 [TBL] [Abstract][Full Text] [Related]
18. The role of Sun J; Fei F; Zhang M; Li Y; Zhang X; Zhu S; Zhang S BMC Cancer; 2019 May; 19(1):450. PubMed ID: 31088406 [TBL] [Abstract][Full Text] [Related]
19. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. Tóth K; Sipos F; Kalmár A; Patai AV; Wichmann B; Stoehr R; Golcher H; Schellerer V; Tulassay Z; Molnár B PLoS One; 2012; 7(9):e46000. PubMed ID: 23049919 [TBL] [Abstract][Full Text] [Related]
20. Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy. Hariharan R; Jenkins M BMJ Open Gastroenterol; 2020; 7(1):e000355. PubMed ID: 32128229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]